Trial Profile
An Open-Label Randomized Phase II Study of Cipterbin or Cipterbin in Combination With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer (MBC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2022
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Sunshine Guojian Pharmaceutical
- 21 Sep 2011 New trial record